glp-1 ra therapy Glucagon-like peptide-1 receptor: mechanisms and advances in Glucagon-Like Peptide-1 Based Therapies: A

17 ZhangHYangPGuXSunYZhangRZhangDet al

In 2023, a trial of 17,604 adults (SELECT) with obesity and without T2DM, followed for over three years, showed a 20 percent reduction in major adverse cardiovascular events

In recent years, it has garnered attention for its potential skin benefits, particularly in lightening pigmentation and promoting an even skin tone

This request includes documentation of your medical necessity for the medication: your BMI, your comorbidities, your previous weight loss attempts, and any other information the insurance company requires

PMID: 31319771

The rate of progress depends on consistency, as well as ongoing adjustments made under the supervision of a healthcare professional